A Tail of Two Cities: Portland(s) Important to Pet Medications Market

A Tail of Two Cities: Portland(s) Important to Pet Medications Market

Two companies – based on opposite sides of the country, but in cities bearing the same name – are trying to disrupt how pet owners receive their pet medications.


Chew on this: New flea & tick medications give pets something to sink teeth into

Chew on this: New flea & tick medications give pets something to sink teeth into

Stay in the know this flea and tick season. Purchase Pet Medications in the U.S., 4th Edition and save 10% through June 3 with promo code PFSAPD2016.

May 10 - Flea and tick products have undergone an upheaval of sorts in recent years. The latest trend has been prescription chewables, now becoming a favorite among veterinarians and pet owners alike, as they are considered easier to administer than topicals. Merial introduced Nexgard in late 2013, and it has since driven Merial’s growth, becomin...


Analyst George Puro talks pet medications on Bloomberg Radio’s Market Minute

Analyst George Puro talks pet medications on Bloomberg Radio’s Market Minute

Full coverage of this important pet industry segment can be found in our reports Pet Medications in the U.S.: Over-the-Counter and Prescription Remedies as Consumer Products, 3rd Edition and U.S. Pet Market Outlook, 2015-2016. Purchase either report-or both-and receive a 5% discount through September using promo code PFPETS2015.

Sales of pet medications are concentrated in the veterinary channel, which accounts for nearly 60% of the market by Packaged Facts estimates. For some types of prescri...


Now fleas and ticks do a little ’dance of death’

Now fleas and ticks do a little ’dance of death’

Ever since Merial’s flea and tick blockbuster Frontline went off patent four years ago, the flea and tick category has been in a state of intense competition. Several other fipronil-based products have made a splash, gnawing away at Frontline’s market share. While Merial has managed to force the withdrawal of some formulations, citing infringement on patents the company still holds, others have made inroads, including products from Sergeant’s (FiproGuard and Pronyl), Novartis (Parastar and EasyS...